Exact Sciences logo — Changing the way we think about detecting and treating cance...

Exact Sciences

Changing the way we think about detecting and treating cancer.

Founded 1995 United States Madison, United States 5326 employees Acquired Total: $23.63B Biotechnology

General Information

Company Name Exact Sciences
Founded Year 1995
Location United States Madison, United States
Employees 5326
Industries Biotechnology
Funding Stage Acquired
Business Model B2B, B2C, D2C
Revenue Model Product Sales, Service Fee, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Exact Sciences. To contact Exact Sciences, visit exactsciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Exact Sciences compare?

A PDF of Exact Sciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Exact Sciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Exact Sciences

Exact Sciences has been redefining the landscape of cancer detection and treatment. Established in 1995 and headquartered in the United States, the company has built a reputation for its innovative approach toward healthcare.

Under the slogan, "Changing the way we think about detecting and treating cancer," Exact Sciences has been charting a new course in cancer diagnostics. Recently, the company was acquired by healthcare giant Abbott, a significant move that aims to harness shared resources and expertise. With this acquisition valued at $21.00B, finalized on 01 November 2025, Exact Sciences is now primed to make a broader global impact.

Abbott, known for its comprehensive portfolio that includes diagnostics, medical devices, and nutritional products, plans to integrate Exact Sciences’ capabilities to further revolutionize healthcare delivery. Through this strategic partnership, the unified entity continues to focus on enhancing global health, serving over 160 countries with a workforce of 122,000 dedicated professionals.

Business keywords: Healthcare Innovation, Cancer Detection, Cancer Treatment, Precision Oncology, Genomic Testing, Cancer Screening, Personalized Medicine, Diagnostics, Nutritional Products, Branded Generic Medicines, Tumor Analysis, Research and Development, Healthcare Technologies, Patient-centered Solutions

Services & Products

Multi-cancer early detection tests
Genomic analysis for cancer treatment
Hereditary cancer risk screening
Research in cancer genomics
Cologuard cancer screening tests
Oncotype DX tests for breast, colon, and liver cancers

Target Customers

Patients Healthcare Providers Doctors Researchers Caregivers Cancer Survivors

Funding Rounds & Investors (13)

View All
Funding Stage Amount Investors Lead Investors Date
Acquisition $21.00B 1
Abbott
01 Nov 2025
Post IPO Convertible $620.70M -
01 Apr 2024
Post-IPO Equity $200.00K 1
Associated Bank
01 Aug 2023
Post IPO Convertible $500.00M -
01 Feb 2023
Post-IPO Debt $850.00M -
01 Feb 2020
Post-IPO Debt $600.00M -
01 Jan 2018
Early VC $8.20M -
01 Jun 2009
IPO Undisclosed -
01 Jan 2001
Series B $31.75M 4
Greylock Partners, Highland Capital +2
01 Apr 2000
Series A $10.54M 5
Greylock Partners, Highland Capital +3
01 Mar 1998

View All 13 Funding Rounds

Exact Sciences Alternatives & Competitors

View All Alternatives
Exact Sciences vs
Abbott
Abbott United States

Life-changing health technologies in the area of diagnostics, medical devices, nutritionals and bran...

IPO
152808 employees
Biotechnology, Health Care
Exact Sciences vs
Ashion Analytics
Ashion Analytics United States

We are an Exact Sciences sequencing-based Clinical laboratory. We tap into the power of the human ge...

3 employees
Biotechnology, Health Care
Exact Sciences vs
Adela, Inc.
Adela, Inc. United States

Advancing the field of epigenomics to transform how cancer is detected and monitored.

70 employees
Biotechnology, Pharmaceutical

FAQ About Exact Sciences

Changing the way we think about detecting and treating cancer.
Exact Sciences was founded in 1995.
Exact Sciences is headquartered in Madison, United States.
Exact Sciences operates in Biotechnology. Its work centres on Healthcare Innovation, Cancer Detection, Cancer Treatment and Precision Oncology. Its customers include Patients, Healthcare Providers and Doctors.
Exact Sciences has a B2B, B2C and D2C business model. Its revenue comes from Product Sales, Service Fee and Usage Based.
Exact Sciences has approximately 5326 employees.
Exact Sciences has completed 13 funding rounds, raising a total of $23.63B. The latest funding stage is Acquired.
Exact Sciences offers: Multi-cancer early detection tests, Genomic analysis for cancer treatment, Hereditary cancer risk screening, Research in cancer genomics, Cologuard cancer screening tests, Oncotype DX tests for breast, colon, and liver cancers.
Top alternatives and competitors to Exact Sciences include Abbott, Ashion Analytics, Adela, Inc., Freenome, Variantyx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Exact Sciences and Abbott are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Exact Sciences, https://bouncewatch.com/company/exact-sciences, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes